Skip to content

Assessment of Home medication review on Quality of life, cost, Medication adherence and glycemic control among Elderly Type-2 Diabetic patients

Impact of Pharmacist-led Home Medication Review on Economic, Clinical, and Humanistic Outcomes in Elderly Type-2 Diabetic Patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093229
Enrollment
200
Registered
2025-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Pharmacist led Home Medication Review (HMR): A trained pharmacist visits patients in their homes to review medications, provide education, and identify and address drug-related problems

Sponsors

NITTE (Deemed to be University)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 60 years or above. Diagnosed with Type 2 Diabetes Mellitus. Currently undergoing standard pharmacotherapy for diabetes management. Willing to provide informed consent and participate in the study

Exclusion criteria

Exclusion criteria: Patients with terminal illnesses. Patients with severe complications of diabetes, such as end-stage renal disease, may be excluded from participation. Patients with psychiatric illnesses or cognitive impairments. Patients with a history of stroke that significantly limits their ability to engage in the intervention or adhere to the study protocol. Uncontrolled comorbidities require immediate intensive care.

Design outcomes

Primary

MeasureTime frame
Change in glycemic control as measured by HbA1c levels.Timepoint: Baseline, 6 months, and 12 months.

Secondary

MeasureTime frame
Change in medication adherence, and Change in quality of life.Timepoint: Baseline, 6 months, and 12 months.;Change in direct medical costs, including hospital visits and medication expenses and Number and category of Drug-Related Problems (DRPs) identified and addressed.Timepoint: Baseline, 6 months, and 12 months.

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

Dept. of General Medicine, Justice K.S. Hegde Charitable Hospital, NITTE (Deemed to be University)

adithibhandary@nitte.edu.in9886517329

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026